122 related articles for article (PubMed ID: 30501725)
1. [Characteristics of CD180 Expression and Its Diagnostic Value in B Cell Chronic Lymphoproliferative Disorders].
Wu J; Sheng Y; Sui JN; Weng XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1811-1815. PubMed ID: 30501725
[TBL] [Abstract][Full Text] [Related]
2. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
3. The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - Results from a single centre pilot study.
Gautam A; Sreedharanunni S; Sachdeva MUS; Rana S; Kashyap D; Bose P; Bal A; Prakash G; Malhotra P; Das R; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1123-1131. PubMed ID: 33455071
[TBL] [Abstract][Full Text] [Related]
4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
5. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
[TBL] [Abstract][Full Text] [Related]
6. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
Poongodi R; Varma N; Naseem S; Parveen B; Varma S
Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
[TBL] [Abstract][Full Text] [Related]
7. CD180 expression in B-cell lymphomas: A multicenter GEIL study.
Mayeur-Rousse C; Guy J; Miguet L; Bouyer S; Geneviève F; Robillard N; Solly F; Maar A; Bené MC; Mauvieux L;
Cytometry B Clin Cytom; 2016 Sep; 90(5):462-6. PubMed ID: 26384474
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data.
Gross Z; Veyrat-Masson R; Grange B; Huet S; Verney A; Traverse-Glehen A; Ruminy P; Baseggio L
Hematol Oncol; 2024 Jan; 42(1):e3245. PubMed ID: 38287532
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.
Fan L; Miao Y; Wu YJ; Wang Y; Guo R; Wang L; Shen AL; Chen YY; Xu W; Li JY
Leuk Lymphoma; 2015; 56(12):3329-35. PubMed ID: 25791119
[TBL] [Abstract][Full Text] [Related]
11. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.
Pedreira CE; Costa ES; Almeida J; Fernandez C; Quijano S; Flores J; Barrena S; Lecrevisse Q; Van Dongen JJ; Orfao A;
Cytometry A; 2008 Dec; 73A(12):1141-50. PubMed ID: 18836994
[TBL] [Abstract][Full Text] [Related]
12. [Hairy lymphoproliferations: a case report and review of the literature].
Julien M; Latger-Cannard V; Salignac S; Aubert C; Gérard D; Broseus J; Lesesve JF
Ann Biol Clin (Paris); 2022 Jun; 80(3):252-258. PubMed ID: 35796473
[TBL] [Abstract][Full Text] [Related]
13. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
Costa ES; Pedreira CE; Barrena S; Lecrevisse Q; Flores J; Quijano S; Almeida J; del Carmen García-Macias M; Bottcher S; Van Dongen JJ; Orfao A
Leukemia; 2010 Nov; 24(11):1927-33. PubMed ID: 20844562
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the brazilian group of flow cytometry (GBCFLUX).
Sales MM; Ferreira SIACP; Ikoma MRV; Sandes AF; Beltrame MP; Bacal NS; Silva MCA; Malvezzi M; Lorand-Metze IGH; Orfao A; Yamamoto M;
Cytometry B Clin Cytom; 2017 Sep; 92(5):398-410. PubMed ID: 27362793
[TBL] [Abstract][Full Text] [Related]
15. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
16. [Research Progress on Diagnosis and Treatment of B Cell Chronic Lymphoproliferative Disease--Review].
Li YY; Hu DZ; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1220-1224. PubMed ID: 30111434
[TBL] [Abstract][Full Text] [Related]
17. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
18. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
[TBL] [Abstract][Full Text] [Related]
19. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
[TBL] [Abstract][Full Text] [Related]
20. Dicentric chromosome 3 associated with binucleated lymphocytes in atypical B-cell chronic lymphoproliferative disorder.
Samson T; Mossafa H; Lusina D; Fagot T; Souleau B; de Revel T; Troussard X; Nedellec G
Leuk Lymphoma; 2002 Sep; 43(9):1749-54. PubMed ID: 12685827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
